Bio

Bio


Dr. Dujari is a neurologist who practices at Stanford Health Care – ValleyCare in Pleasanton. She is also a clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.

She is dedicated to continuously improving the quality of patient care. She places special emphasis on enhancing patient-doctor communication.

She has made presentations to Stanford University School of Medicine on the treatment of bacterial meningitis and the management of thunderclap headaches in the emergency department. Posters co-developed by Dr. Dujari on quality improvement and patient safety advances have been presented at the Neurohospitalist Society Meeting and American Academy of Neurology Annual Meeting.

Dr. Dujari has earned honors from Stanford University School of Medicine, Boston University School of Medicine, and University of California, Davis. She also received the American Academy of Neurology Annual Meeting resident scholarship.

She is a member of the American Academy of Neurology and Alpha Omega Alpha Medical Honor Society. She is also a member of the Stanford Hospital Neurology Quality Council.

Dr. Dujari has led teams including the Resident Safety Council of Stanford Hospital, which designs and implements improvements in the patient healthcare experience, with a focus on improving communication about medication side effects. She led the wellness initiative of the Stanford Neurology Wellness and Mentoring Program to reduce resident burnout and increase peer-to-peer mentorship.

In addition, she co-founded Dance for Health at Boston University School of Medicine, which taught dance classes at assisted living and senior centers to improve motor coordination and create a social outlet for the elderly.

Clinical Focus


  • Neurology
  • Headache
  • Meningitis
  • Stroke

Academic Appointments


Professional Education


  • Board Certification: American Board of Psychiatry and Neurology, Neurology (2020)
  • Fellowship: Stanford University Dept of Neurology (2021) CA
  • Residency: Stanford University Neurology Residency (2020) CA
  • Internship: California Pacific Medical Center Dept of Medicine (2017) CA
  • Medical Education: Boston University School of Medicine (2016) MA
  • Residency, Stanford University Neurology Residency (2020)
  • Internship, California Pacific Medical Center Internal Medicine Residency (2017)
  • Medical Education, Boston University School of Medicine (2016)

Publications

All Publications


  • Administration of Dexamethasone for Bacterial Meningitis: An Unreliable Quality Measure. The Neurohospitalist Dujari, S. n., Gummidipundi, S. n., He, Z. n., Gold, C. A. 2021; 11 (2): 101–6

    Abstract

    To validate the use of administrative data to identify patients with bacterial meningitis and quantify the rate of dexamethasone administration as defined in the American Academy of Neurology Inpatient and Emergency Care Quality Measurement Set.The Vizient Clinical Data Base and Resource Manager was used to identify patients with International Classification of Diseases, Tenth Revision (ICD-10) codes for bacterial meningitis from October 2015 to June 2019. Chart review was performed on patients identified at a single quaternary-care hospital. The positive predictive value (PPV) of Vizient was determined. Demographic, clinical, and laboratory data were assessed using descriptive statistics.Of all hospitals that submitted complete data to Vizient during the study period, a median of 19 patients per hospital had ICD-10 codes for bacterial meningitis in the 45-month period. We identified 79 patients using Vizient at our institution of whom 69 had a diagnosis of bacterial meningitis confirmed by chart review (PPV = 87%). 15 patients were eligible to receive dexamethasone per the quality measurement set. Six of these patients (40%) received dexamethasone.It is feasible to use the Vizient Clinical Data Base and Resource Manager to identify patients with bacterial meningitis. Due to low prevalence across multiple institutions and high rate of exclusion criteria at our institution, this study suggests that the rate of dexamethasone administration in bacterial meningitis may be an unreliable indicator of quality of care provided by inpatient neurologists. The creation of a registry for hospitalized neurology patients could enhance development of future quality measures.

    View details for DOI 10.1177/1941874420969556

    View details for PubMedID 33791051

    View details for PubMedCentralID PMC7958681

  • ACEP Guidelines on Acute Nontraumatic Headache Diagnosis and Management in the Emergency Department, Commentary on Behalf of the Refractory, Inpatient, Emergency Care Section of the American Headache Society. Headache Peretz, A. n., Dujari, S. n., Cowan, R. n., Minen, M. n. 2020

    Abstract

    The American College of Emergency Physicians (ACEP) published guidelines in July 2019 on the diagnosis and management of acute nontraumatic headaches in the emergency department, focusing predominantly on the diagnosis of subarachnoid hemorrhage and the role of imaging and lumbar puncture in diagnosis. The ACEP Clinical Policies document is intended to aide Emergency Physicians in their approach to patients presenting with acute headache and to improve the accuracy of diagnosis, while promoting safe patient care practices. The Clinical Policies document also highlights the need for future research into best practices to distinguish primary from secondary headaches and the efficacy and safety of current treatment options for acute headaches. The following commentary on these guidelines is intended to support and expand on these guidelines from the Headache specialists' perspective, written on behalf of the Refractory, Inpatient, Emergency Care section of the American Headache Society (AHS). The commentary have been reviewed and approved by Board of Directors of the AHS.

    View details for DOI 10.1111/head.13744

    View details for PubMedID 31944291

  • Utilization, yield, and accuracy of the FilmArray Meningitis/Encephalitis panel with diagnostic stewardship and testing algorithm. Journal of clinical microbiology Broadhurst, M. J., Dujari, S. n., Budvytiene, I. n., Pinsky, B. A., Gold, C. A., Banaei, N. n. 2020

    Abstract

    Background: The impact of diagnostic stewardship and testing algorithms on utilization and performance of the FilmArray® Meningitis/Encephalitis (ME) Panel has received limited investigation.Methods: We performed a retrospective single-center cohort study assessing all individuals with suspected ME between February 2017 and April 2019 for whom the ME Panel was ordered. Testing was restricted to patients with cerebrospinal fluid (CSF) pleocytosis. Positive ME Panel results were confirmed before reporting through correlation with direct stain (Gram and Calcofluor white) and CSF Cryptococcal antigen or by repeat ME Panel testing. Outcomes included ME Panel test utilization rate, negative predictive value of non-pleocytic CSF samples, test yield and false-positivity rate, and time to appropriate de-escalation of acyclovir.Results: Restricting testing to pleocytic CSF samples reduced ME Panel utilization by 42.7% (263 vs 459 tests performed) and increased test yield by 61.8% (18.6% vs 11.5% positivity rate; P < 0.01) with application of criteria. The negative predictive value of normal CSF WBC for ME Panel targets was 100% (195/195) for non-viral targets and 98.0% (192/196) overall. All pathogens detected in non-pleocytic CSF samples were herpesviruses. Application of a selective testing algorithm based on repeat testing of non-viral targets avoided 75% (3/4) of false-positive results without generating false-negative results. Introduction of the ME panel reduced the duration of acyclovir treatment from an average of 66 hours (SD, 43) to 46 hours (SD, 36) (P = 0.03).Conclusions: Implementation of the ME Panel with restriction criteria and a selective testing algorithm for non-viral targets optimizes its utilization, yield and accuracy.

    View details for DOI 10.1128/JCM.00311-20

    View details for PubMedID 32493787

  • Infected Implantable Pulse Generator NEUROHOSPITALIST Dujari, S., Gold, C. A. 2019; 9 (3): 172–73

    View details for DOI 10.1177/1941874418809869

    View details for Web of Science ID 000471642900011

    View details for PubMedID 31244976

    View details for PubMedCentralID PMC6582390

  • Making Well Neurologists: A Multifaceted Program for Neurology Trainee and Faculty Wellbeing Miller-Kuhlmann, R., Murray, N., Dujari, S., Karamian, A., Hamidi, M., Su, E., Bozinov, N., McGranahan, T. LIPPINCOTT WILLIAMS & WILKINS. 2019
  • Design and Implementation of a Novel Acute Stroke Code for the Extended Window of Endovascular Treatment Legault, C., Dujari, S., Shen, S. H., Wagner, A. M., Albers, G., Bernier, E., Callagy, P., Vora, N. LIPPINCOTT WILLIAMS & WILKINS. 2018

Latest information on COVID-19